home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

2-day In-person Seminar on “Quality System Regulations for Drugs, Devices, and Tablets and How to generate your DMF” at Philadelphia

 
  September 01, 2014  
     
 


GlobalCompliancePanel, 237 South Broad Street, Philadelphia, Pennsylvania, 19107-5686, USA
2014-10-23


Detailed Description:

Primary Student Objectives - General High Level Topics where we will move down to very specific discussion and details to generate a much higher comprehension for quality individuals even though during this course you will not have to take a final exam!

Upon completing this course participants will gain a much better Quality Systems comprehension, based on the instructor's decades of experience helping generate quality system regulations, working with the FDA, fixing FDA findings and generating a synergistic discussion with the attendees to help us all make sure we understand that there is rarely ever on "one" way to do things or "right and wrong", just like making an assumption about the Root Cause of an incident rather than working together to realize there are other things that took place that the individual making the assumption may not have been aware of.

1. What is expected from the QA professional and how other industries (FAA, ISO, EPA, etc.) have made Quality Systems so profitable by having the Head of Operations and the Head of Quality trading places every 6 months?

2. Gaining a more practical Comprehension from experience of the Quality Systems regulations not just reading and thinking you are an expert (reading three books on how to ride a bicycle does not make you an expert).

3. Once we have a better perspective then we will identify the necessary activities like working on a thesis to generate the needed performance for the entire Quality System.

4. How to apply current technology to generate the objective evidence needed to generate the attitude of making the FDA successful when inspecting by answering all the potential inspector questions before asked. Use the applicable technology to think like an FDA inspector

5. How are we going to maintain documented evidence to prove that the process and initial validation is still working in accordance with the Quality System regulations

6. Make sure we have the proper tools and comprehension to perform the needed internal audits which ensures that when a client audits the company or the FDA inspects the facility, we have already been doing all the things they might be reviewing.

7. Making sure that all the laboratory, inspection, calibration, and related quality verification activities are working in a way that generates higher profitability by generating continuous quality improvement (CQI)

8. Ensuring that vendors are practicing the similar quality performance to make sure we don't get hit by their lack of consistency and quality performance based on the needed specifications for our process or products.

9. Defining the expected although not actually defined by the FDA what we need to demonstrate GDP (good documentation practices) which also serve as "legal" documents if something negative happens.

10. Management of Incidents, Deviations, Changes - Incident tracking systems(ITS), deviation management (OOS, OOT, OOL, etc.), Critical Change Control (CCR) and Corrections, Corrective Action and Preventative Action (CAPA).

11. Batch Production Record (BPR) or Device History Record (DHR) related to the master versions of the documents used for production and the review before release.

12. How to use statistics for Quality Systems and make sure that 6 Sigma is not being used during the validation activities.

 

Audience:

Senior quality managers, Quality professionals, Regulatory professionals, Compliance professionals, Production supervisors, New FDA Inspectors, Manufacturing engineers, Production engineers, Design engineers, Process owners, Quality engineers, Quality auditors, Document control specialists, Record retention specialists, Marketing and Medical Affairs, Legal Professionals

Meet your Expert:

Mr. Jerry Dalfors has extensive (40+ years) of business administration, consultative, technical and managerial experience in the development and manufacture of highly regulated biopharmaceutical products including injectable, biologics, medical devices and oral dosages. He has held permanent employee, temporary employee and company representative management positions with a multitude of the major pharmaceutical and biotechnology companies in the US. He has worked with or assisted more than two dozen companies with the establishment of controlled document/quality systems, FDA briefing and submittal documents, project management of several multimillion dollar projects including design, start-up and validation to assure fast track FDA approval by maintaining strict regulatory compliance during all phases of engineering, construction, commissioning and validation, and has written numerous submission documents for product, process and facility approval/licensing which also required the development of quality systems which included customer complaint management, deviation management, CAPA and associated site wide employee training.

 

RAC Credits: 12

Date: October 23rd & 24th, 2014

Event Details: http://bit.ly/quality-system-regulations

Location: Philadelphia, PA

Venue: DoubleTree by Hilton Hotel Philadelphia Center City

Venue Address: 237 South Broad Street, Philadelphia, Pennsylvania, 19107-5686, USA

Registration: Open Enrollment

Delivery: Face-to-Face event

Price: $1295.00

Until September 30, Early Bird Price: $1,295.00

From October o1 to October 21, Regular Price: $1,495.00

 

Objective:

Method Development and related activities associated with Technology Transfer - Quality Testing as well as Production Lecture and Validation, Verification and on-going Cost Savings programs to generate Continuous Quality Improvement. Regulatory requirements for setting up Procedures and BPRs / DHRs including the Master Records to make sure we are minimizing operator error and making the Document Review process more effective and cheaper prior to Product Release.

 

Course Web Site: https://www.globalcompliancepanel.com/control/~product_id=900105SEMINAR/quality-system-regulations-drugs

Organizer:
GlobalCompliancePanel imparts knowledge of best practices in industry to guarantee effective implementation of compliance programs for meeting regulatory demands. The key focus of GlobalCompliancePanel is to provide extensive and quality training for risk management, regulatory compliances, corporate governance and quality management.

Our Achievements:

Over 300 Experts that are Renowned in their Respective Areas

Successfully Trained more than 20,000 Compliance Professionals

A Most Comprehensive Portal for Trainings, Industry Updates and Professional Growth

Having more than 2000 Online Courses

Successfully Completed more than 170 Seminars in US and Globally

 

Provider:

GlobalCompliancePanel

                John Robinson

                161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA

                Phone: 1800-447-9407

                Fax: 302-288-6884

                Email: support@globalcompliancepanel.com

                Website: www.globalcompliancepanel.com

 
 
Organized by: GlobalCompliancePanel
Invited Speakers:

Mr. Jerry Dalfors has extensive (40+ years) of business administration, consultative, technical and managerial experience in the development and manufacture of highly regulated biopharmaceutical products including injectable, biologics, medical devices and oral dosages. He has held permanent employee, temporary employee and company representative management positions with a multitude of the major pharmaceutical and biotechnology companies in the US. He has worked with or assisted more than two dozen companies with the establishment of controlled document/quality systems, FDA briefing and submittal documents, project management of several multimillion dollar projects including design, start-up and validation to assure fast track FDA approval by maintaining strict regulatory compliance during all phases of engineering, construction, commissioning and validation, and has written numerous submission documents for product, process and facility approval/licensing which also required the development of quality systems which included customer complaint management, deviation management, CAPA and associated site wide employee training. 

 
Deadline for Abstracts: 2014-10-23
 
Registration:

 Date: October 23rd & 24th, 2014

Phone: 1800-447-9407

                Fax: 302-288-6884

                Email: support@globalcompliancepanel.com

                Website: www.globalcompliancepanel.com

Event Details: http://bit.ly/quality-system-regulations 

E-mail: globalcompliancepanel@gmail.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.